<DOC>
	<DOCNO>NCT01970059</DOCNO>
	<brief_summary>The aim present study evaluate efficacy safety Extended-Release Carvedilol Sulfate versus Patients With Mild Moderate Primary Hypertension</brief_summary>
	<brief_title>A Phase Ⅲ Study Extended-Release Carvedilol Sulfate Treatment Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Males Females Aged 18 70 year Had history essential hypertension Average sit diastolic blood pressure≧90mmHg，but≦109mmHg Malignant hypertension Average sit systolic blood pressure≧180mmHg Type 2 diabetes hemoglobin A1c≥9 % Type 1 diabetes New York Heart Association class ⅡⅣ congestive heartfailure Unstable angina Second third degree heart block history sick sinus syndrome unless pacemaker place Atrial fibrillation Bradycardia ( &lt; 60 bpm , seat ) Asthma obstructive pulmonary disease History myocardial infarction Stroke 6 month screen Known contraindication βadrenergic blocker therapy Glutamicoxaloacetic transaminase and/or glutamicpyruvic transaminase＞3 time upper limit normal Crea＞2 time upper limit normal Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Hypertension</keyword>
</DOC>